0071430
Bard 100cc Silicone Closed Wound Suction Evacuator Kit
$11.50
eaches
In Stock: 6 Eaches
Expiration:
In-Date
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
Medtronic Monosof black 18" P-10 cutting (SN5697)
$1.00 packets
Medtronic Biosyn undyed 30" V-20 taper
$165.00 box of 36
Medtronic Monosof black 18" P-16 cutting
$99.00 box of 12
Medtronic Maxon green 30" CV-23 taper
$5.25 packets
Medtronic Biosyn undyed 30" GS-11 Heavy Body Reverse Cutting
$85.00 box of 36
Medtronic Biosyn undyed 30" GS-21 taper
$141.50 box of 36
Medtronic Biosyn undyed 30" C-13 cutting
$5.10 packets
Medtronic Biosyn undyed 30" GS-21 taper
$94.50 box of 36
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Type | Drainage | Wound |
| Unit | eaches |
- FDA Product Code: GCY
- FDA Product Code Name: APPARATUS, SUCTION, SINGLE PATIENT USE, PORTABLE, NONPOWERED
- GMDN Term Code: 11301
- GMDN Term Name: Closed-wound/centesis drainage receptacle
- GMDN Term Description: A sterile container designed to be connected to an invasive drain/drainage catheter (not included) to collect fluids or purulent material being removed during drainage of a body cavity, a closed-wound, and/or the bile duct; it is not intended for drainage of cerebrospinal fluid (CSF) or blood. It is typically in the form of a bottle, bag, or bulb with fluid volume markers, and might include a hand-operated pump (e.g., suction bulb) and tubing; it does not include any invasive components or powered devices. This is a single-use device.
Bard
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.